Charnwood Molecular, a leading UK-based pre-clinical discovery CRO serving the global pharmaceutical and biotechnology market, has launched a new website outlining in detail the company’s integrated drug discovery capabilities.
The new site clearly sets out the company’s integrated drug discovery services along with its capabilities in bioscience, medicinal chemistry, computational chemistry and early scale-up.
The new website has been created after consultation with Charnwood Molecular’s clients and team, to apply improvements to the site.
The new site also includes dedicated sections for drug discovery, therapeutic areas, target classes and resources.
Amongst other enhancements, there is improved navigation making it easier to see how Charnwood Molecular can work with clients as an integrated drug discovery service provider.
The new website is the latest in a line of key developments for Charnwood Molecular, with the company having very recently officially opened its flagship new facilities at Charnwood Campus, Loughborough. These premises house the company’s key scientific teams working on areas from bioscience through to medicinal chemistry.
Charnwood Molecular is ideally placed now to offer an ever-expanding number of services.
